Reprogramming of serine, glycine and one-carbon metabolism in cancer

Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165841. doi: 10.1016/j.bbadis.2020.165841. Epub 2020 May 19.

Abstract

Metabolic pathways leading to the synthesis, uptake, and usage of the nonessential amino acid serine are frequently amplified in cancer. Serine encounters diverse fates in cancer cells, including being charged onto tRNAs for protein synthesis, providing head groups for sphingolipid and phospholipid synthesis, and serving as a precursor for cellular glycine and one-carbon units, which are necessary for nucleotide synthesis and methionine cycle reloading. This review will focus on the participation of serine and glycine in the mitochondrial one-carbon (SGOC) pathway during cancer progression, with an emphasis on the genetic and epigenetic determinants that drive SGOC gene expression. We will discuss recently elucidated roles for SGOC metabolism in nucleotide synthesis, redox balance, mitochondrial function, and epigenetic modifications. Finally, therapeutic considerations for targeting SGOC metabolism in the clinic will be discussed.

Keywords: Cancer; Glycine; Metabolism; Mitochondria; One-carbon; Serine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Carbon / metabolism
  • Cellular Reprogramming / physiology*
  • Glycine / metabolism*
  • Humans
  • Metabolic Networks and Pathways
  • Methionine / metabolism
  • Mitochondria / metabolism
  • Neoplasms / metabolism*
  • Protein Processing, Post-Translational
  • Serine / metabolism*
  • Transcription Factors

Substances

  • Transcription Factors
  • Serine
  • Carbon
  • Methionine
  • Glycine